Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet A-Cells Into B-Cells in Vivo

Total Page:16

File Type:pdf, Size:1020Kb

Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet A-Cells Into B-Cells in Vivo Diabetes Volume 66, May 2017 1293 Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet a-Cells Into b-Cells In Vivo Taka-aki Matsuoka,1 Satoshi Kawashima,1 Takeshi Miyatsuka,1,2 Shugo Sasaki,1 Naoki Shimo,1 Naoto Katakami,1 Dan Kawamori,1 Satomi Takebe,1 Pedro L. Herrera,3 Hideaki Kaneto,4 Roland Stein,5 and Iichiro Shimomura1 Diabetes 2017;66:1293–1300 | DOI: 10.2337/db16-0887 Among the therapeutic avenues being explored for re- including coronary and renal disease. A variety of innova- placement of the functional islet b-cell mass lost in tive approaches are being explored to produce b-cells from type 1 diabetes (T1D), reprogramming of adult cell types embryonic stem cells (1,2) and adult cell types (3–5). A into new b-cells has been actively pursued. Notably, supposition in these efforts involves producing conditions mouse islet a-cells will transdifferentiate into b-cells un- that correctly regulate the transcription factor networks der conditions of near b-cell loss, a condition similar to required in programming pancreatic progenitor cells into ISLET STUDIES a T1D. Moreover, human islet -cells also appear to poised b-cells and subsequently controlling mature islet cell func- for reprogramming into insulin-positive cells. Here we tion. These include transcription factors like Pdx1 (6–10), have generated transgenic mice conditionally expressing which is essential in the formation of early pancreatic ep- the islet b-cell–enriched Mafa and/or Pdx1 transcription ithelium, developing b-cells and adult islet b-cells, as well factors to examine their potential to transdifferentiate as neurogenin 3 (Ngn3) (11–13), which is required during embryonic pan–islet cell Ngn3-positive progenitors and embryogenesis for specification of all islet cell types (i.e., the later glucagon-positive a-cell population into b-cells. b-cells, glucagon hormone–producing a-cells, somatostatin Mafa was found to both potentiate the ability of Pdx1 d to induce b-cell formation from Ngn3-positive endocrine -cells, pancreatic polypeptide (PP) cells, and ghrelin e precursors and enable Pdx1 to produce b-cells from -cells). In addition, there are transcription factors like fl a-cells. These results provide valuable insight into the Mafa (14,15) that are in uential later during postnatal b fundamental mechanisms influencing islet cell plasticity -cell maturation and adult cell function. Indeed, ectopic in vivo. expression of Pdx1, Ngn3, and Mafa can reprogram pan- creatic exocrine cells (3) and intestinal cells (4) into func- tional b-like cells in vivo. While current therapies of insulin treatment afford T1D results from the specific loss of islet b-cells. In- glycemic control to patients with type 1 diabetes (T1D), terestingly, functional b-like cells are produced from en- these relatively static methods do not completely recapit- dogenous mouse islet a-cells (16) or d-cells (17) after near ulate the acute regulation of the endogenous islet b-cells total targeted destruction of this cell population, a model destroyed by autoimmune destruction. Consequently, pa- mimicking the disease state (16). Furthermore, epigenomic tients with T1D have a dramatically shortened life expec- findings suggest that human a-cells are poised for reprog- tancy due to serious long-term diabetes complications, ramming, with treatment to prevent histone 3 repressor 1Department of Metabolic Medicine, Osaka University Graduate School of Med- Corresponding author: Taka-aki Matsuoka, [email protected]. icine, Osaka, Japan Received 20 July 2016 and accepted 6 February 2017. 2Center for Molecular Diabetology, Juntendo University Graduate School of Med- This article contains Supplementary Data online at http://diabetes icine, Tokyo, Japan .diabetesjournals.org/lookup/suppl/doi:10.2337/db16-0887/-/DC1. 3Department of Genetic Medicine and Development, University of Geneva Faculty of Medicine, Geneva, Switzerland © 2017 by the American Diabetes Association. Readers may use this article as 4Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical long as the work is properly cited, the use is educational and not for profit, and the School, Okayama, Japan work is not altered. More information is available at http://www.diabetesjournals 5Department of Molecular Physiology and Biophysics, Vanderbilt University Med- .org/content/license. ical School, Nashville, TN 1294 Competency of Mafa for Reprogramming Islet Cells Diabetes Volume 66, May 2017 site marking at lysine 27 leading to the appearance of in- Olympus FV1000-D confocal microscope. The images sulin-positive–glucagon-positive bihormonal cells in human shown are representative of our analysis of at least three islets (18). independently derived mice unless otherwise specified. Here, we generated transgenic mice that allow condi- The total number of insulin-, glucagon-, PP-, and tionally and targeted expression of Mafa or Pdx1 to b-gal–positive cells in five sections per pancreas from at determine their contribution to b-cell generation from least three mice per genotype were manually counted in embryonic endocrine Ngn3-positive and committed gluca- the Ngn3-Cre (Figs. 1D and 2B) and Gcg-Cre (Fig. 3D) gon-positive progenitors. Earlier studies had established lines. Approximately 500 cells were counted in the that forced Pdx1 expression in this endocrine precursor 6-week-old pancreas and 200 cells in the P0.5 pancreas. population results in greater b-cell production at the ex- The data are presented as the ratio of each hormone- pense of a-cells, with no effect on d-cells or PP cells (19). positive cell or hormone-positive–to–b-gal–positive cell We found that Mafa not only was found to potentiate the for each genotype. ability of Pdx1 to reprogram Ngn3-positive endocrine progenitor cells to insulin-positive cells but also empow- Statistical Analysis ered Pdx1 to transdifferentiate committed glucagon- Statistical analysis was performed using one-way ANOVA positive a-cells to this cell fate. These results provide followed by the Fisher test. A value of P , 0.05 was further support for the essential role of Mafa and Pdx1 considered to be statistically significant. in the production of therapeutic b-cells for treatment of patients with T1D. RESULTS Mafa + Pdx1 More Efficiently Programs Endocrine RESEARCH DESIGN AND METHODS Ngn3-Positive Precursors to b-Cells Than Pdx1 Alone fl fl CAG-CAT-Pdx1 ag, CAG-CAT-Mafamyc, Cre, To explore how Mafa in uences the ability of Pdx1 to and ROSA26 Mice convert a-cells into b-cells, we developed mouse lines that fl CAG-CAT-Mafamyc (20), CAG-CAT-Pdx1 ag (21), Ngn3-Cre allow for conditional and heritably overproduction of ei- (12), Gcg-Cre (22), ROSA26-LacZ (23), and ROSA26-GFP (24) ther Mafa, Pdx1, or Mafa + Pdx1 upon expression of Cre mice have previously been described. All animal procedures recombinase (Fig. 1A). Antibodies to Mafa and Pdx1 and were approved by the Ethics Review Committee for Animal their incorporated antigenic tags were used to immunohis- Experimentation of the Osaka University Graduate School tochemically detect the levels of the transgenic proteins, myc flag of Medicine. termed Mafa and Pdx1 . Both of these islet b-cell– enriched proteins (27–29) were now found throughout Immunohistochemistry and Cell Quantification the islet cell population upon activation in embryonic en- Pancreata were dissected and fixed in 4% paraformalde- docrine precursors with Ngn3-driven Cre, which were hyde in PBS at 4°C, washed in PBS, immersed in sucrose termed the Ngn3-Cre;CAT-Mafa and Ngn3-Cre;CAT-Pdx1 solution, embedded and frozen in Tissue-Tek (O.C.T. Com- lines. For example, flag-tagged Pdx1 was produced in pound; Sakura), or processed routinely for paraffinembed- essentially all islet cells in P0.5 and 6-week-old Ngn3-Cre; ding. Frozen and paraffin blocks were sectioned at 6-mm CAT-Pdx1 mice; the penetrance rate was ;95% in the in- thickness and immunostained. The following primary an- sulin-positive and glucagon-positive cell populations (Sup- fl tibodies were used at the given dilutions: rabbit anti-MafA plementary Fig. 1). Notably, neither Mafamyc nor Pdx1 ag (1:500) (Bethyl Laboratories, Inc., Montgomery, TX); goat was expressed in the surrounding acinar or ductal cells of anti-MafA (25) (1:200); rabbit anti-Pdx1 (26) (1:1,000); the pancreas (Fig. 1B). While there was no overt effect on rabbit anti-Nkx6.1 (1:200) (Sigma-Aldrich, St. Louis, a-cell fate in Ngn3-Cre;CAT-Mafa islets (Fig. 1C and D), in- MO); rabbit anti-MafB (1:200) (Bethyl Laboratories, Inc.); sulin was expressed in ;10% of Ngn3-Cre;CAT-Pdx1 glucagon- goat anti-Arx (1:200) (Santa Cruz Biotechnology, Inc., positive cells at P0.5. These double hormone–positive cells Dallas, TX); rabbit anti-myc (1:200) (Cell Signaling Technol- resolved to become only insulin-positive by 6 weeks, with ogy,Inc.,Danvers,MA);rabbitanti-flag (1:100) (Affinity essentially no islet glucagon-positive cells remaining (Fig. BioReagents, Golden, CO); mouse anti-flag (1:500) (Trans- 1C), as previously reported (19). Moreover, there was no fl Genic Inc., Kobe, Japan); rabbit anti-Glut2 (1:200) (abcam, evidence for apoptosis within Mafamyc– and Pdx1 ag–positive Cambridge, U.K.); guinea pig anti-insulin (1:2,000) (DAKO, islet glucagon-positive or insulin-positive cells, with the Glostrup, Denmark); rabbit anti-glucagon (1:500) (DAKO); TUNEL-positive signal detected exclusively from red blood guinea pig anti-glucagon (1:200) (Millipore, St. Charles, MO); cells (Supplementary Fig. 2). These results suggested fl rabbit anti–b-galactosidase (b-gal) antibody (1:200) that resolution of the Mafamyc +Pdx1 ag–positive cells (Medical and Biological Laboratories, Nagoya, Japan); to monohormonal insulin production reflects transdiffer- chicken anti–b-gal antibody (1:200) (abcam); and chicken entiation of a-tob-like cells. anti–green fluorescent protein (GFP) antibody (1:500) Mafa expression in endocrine precursor cells augmented (abcam).
Recommended publications
  • RBP-J Signaling − Cells Through Notch Novel IRF8-Controlled
    Sca-1+Lin−CD117− Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IRF8-Controlled Regulatory Dendritic Cells through Notch −RBP-J Signaling This information is current as of September 25, 2021. Xingxia Liu, Shaoda Ren, Chaozhuo Ge, Kai Cheng, Martin Zenke, Armand Keating and Robert C. H. Zhao J Immunol 2015; 194:4298-4308; Prepublished online 30 March 2015; doi: 10.4049/jimmunol.1402641 Downloaded from http://www.jimmunol.org/content/194/9/4298 Supplementary http://www.jimmunol.org/content/suppl/2015/03/28/jimmunol.140264 http://www.jimmunol.org/ Material 1.DCSupplemental References This article cites 59 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/194/9/4298.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 25, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Sca-1+Lin2CD1172 Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IRF8-Controlled Regulatory Dendritic Cells through Notch–RBP-J Signaling Xingxia Liu,*,1 Shaoda Ren,*,1 Chaozhuo Ge,* Kai Cheng,* Martin Zenke,† Armand Keating,‡,x and Robert C.
    [Show full text]
  • Microglia Emerge from Erythromyeloid Precursors Via Pu.1- and Irf8-Dependent Pathways
    ART ic LE S Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways Katrin Kierdorf1,2, Daniel Erny1, Tobias Goldmann1, Victor Sander1, Christian Schulz3,4, Elisa Gomez Perdiguero3,4, Peter Wieghofer1,2, Annette Heinrich5, Pia Riemke6, Christoph Hölscher7,8, Dominik N Müller9, Bruno Luckow10, Thomas Brocker11, Katharina Debowski12, Günter Fritz1, Ghislain Opdenakker13, Andreas Diefenbach14, Knut Biber5,15, Mathias Heikenwalder16, Frederic Geissmann3,4, Frank Rosenbauer6 & Marco Prinz1,17 Microglia are crucial for immune responses in the brain. Although their origin from the yolk sac has been recognized for some time, their precise precursors and the transcription program that is used are not known. We found that mouse microglia were derived from primitive c-kit+ erythromyeloid precursors that were detected in the yolk sac as early as 8 d post conception. + lo − + − + These precursors developed into CD45 c-kit CX3CR1 immature (A1) cells and matured into CD45 c-kit CX3CR1 (A2) cells, as evidenced by the downregulation of CD31 and concomitant upregulation of F4/80 and macrophage colony stimulating factor receptor (MCSF-R). Proliferating A2 cells became microglia and invaded the developing brain using specific matrix metalloproteinases. Notably, microgliogenesis was not only dependent on the transcription factor Pu.1 (also known as Sfpi), but also required Irf8, which was vital for the development of the A2 population, whereas Myb, Id2, Batf3 and Klf4 were not required. Our data provide cellular and molecular insights into the origin and development of microglia. Microglia are the tissue macrophages of the brain and scavenge dying have the ability to give rise to microglia and macrophages in vitro cells, pathogens and molecules using pattern recognition receptors and in vivo under defined conditions.
    [Show full text]
  • PAX4 R192H and P321H Polymorphisms in Type 2 Diabetes and Their Functional Defects
    Journal of Human Genetics (2016) 61, 943–949 & 2016 The Japan Society of Human Genetics All rights reserved 1434-5161/16 www.nature.com/jhg ORIGINAL ARTICLE PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects Jatuporn Sujjitjoon1,6, Suwattanee Kooptiwut2,6, Nalinee Chongjaroen3, Namoiy Semprasert2, Wanthanee Hanchang2, Kanjana Chanprasert3,4, Watip Tangjittipokin3, Pa-thai Yenchitsomanus1 and Nattachet Plengvidhya5 We have previously identified PAX4 mutations causing MODY9 and a recent genome-wide association study reported a susceptibility locus of type 2 diabetes (T2D) near PAX4. In this study, we aim to investigate the association between PAX4 polymorphisms and T2D in Thai patients and examine functions of PAX4 variant proteins. PAX4 rs2233580 (R192H) and rs712701 (P321H) were genotyped in 746 patients with T2D and 562 healthy normal control subjects by PCR and restriction- fragment length polymorphism method. PAX4 variant proteins were investigated for repressor function on human insulin and glucagon promoters and for cell viability and apoptosis upon high glucose exposure. Genotype and allele frequencies of PAX4 rs2233580 were more frequent in patients with T2D than in control subjects (P = 0.001 and 0.0006, respectively) with odds ratio of 1.66 (P = 0.001; 95% confidence interval, 1.22–2.27). PAX4 rs712701 was not associated with T2D but it was in linkage disequilibrium with rs2233580. The 192H/321H (A/A) haplotype was more frequent in T2D patients than in controls (9.5% vs 6.6%; P = 0.009). PAX4 R192H, but not PAX4 P321H, impaired repression activities on insulin and glucagon promoters and decreased transcript levels of genes required to maintain β-cell function, proliferation and survival.
    [Show full text]
  • Roles and Regulation of Transcription Factor Mafa in Islet Β-Cells
    Endocr. J./ S. ARAMATA et al.: INSULIN TRANSCRIPTION AND MafA doi: 10.1507/endocrj.KR-101 REVIEW Roles and Regulation of Transcription Factor MafA in Islet β-cells * SHINSAKU ARAMATA, SONG-IEE HAN AND KOHSUKE KATAOKA Graduate School of Biological Science, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma, Nara 630-0192, Japan *Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba Science City, Ibaraki 305-8572, Japan. Released online August 30, 2007 Correspondence to: Kohsuke KATAOKA, Graduate School of Biological Science, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma, Nara 630-0192, Japan Abstract. Insulin is a critical hormone in the regulation of blood glucose levels. It is produced exclusively by pancreatic islet β-cells. β-cell-enriched transcription factors, such as Pdx1 and Beta2, have dual roles in the activation of the insulin gene promoter establishing β-cell-specific insulin expression, and in the regulation of β-cell differentiation. It was shown that MafA, a β-cell-specific member of the Maf family of transcription factors, binds to the conserved C1/RIPE3b element of the insulin promoter. The Maf family proteins regulate tissue-specific gene expression and cell differentiation in a wide variety of tissues. MafA acts synergistically with Pdx1 and Beta2 to activate the insulin gene promoter, and mice with a targeted deletion of mafA develop age-dependent diabetes. MafA also regulates genes involved in β-cell function such as Glucose transporter 2, Glucagons-like peptide 1 receptor, and Prohormone convertase 1/3. The abundance of MafA in β-cells is regulated at both the transcriptional and post-translational levels by glucose and oxidative stress.
    [Show full text]
  • Context-Specific A-To-B-Cell Reprogramming by Forced Pdx1
    Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press RESEARCH COMMUNICATION from a cells via a bihormonal glucagon+insulin+ (Gcg+Ins+) Context-specific a-to-b-cell transitional state (Thorel et al. 2010). The interconversion reprogramming by forced presumably occurs in response to a combination of the physiological need to replenish b cells and regeneration- Pdx1 expression induced stress, raising questions as to the local or systemic 1 2 1 signals triggered by such lesions. Direct superimposition of Yu-Ping Yang, Fabrizio Thorel, Daniel F. Boyer, apro-b-lineage condition was reported when Pax4 expres- Pedro L. Herrera,2 and Christopher V.E. Wright1,3 sion was forced in pancreatic or endocrine progenitors or in 1 embryonic a cells to redirect endocrine differentiation or Vanderbilt University Program in Developmental Biology, coax pre-existing a cells into b cells. The converted cells Department of Cell and Developmental Biology, Vanderbilt seemed similar to normal b cells and temporarily im- University Medical Center, Nashville, Tennessee 37232, USA; 2 proved glycemia under induced diabetes, although the Department of Cell Physiology and Metabolism, University effect was superseded by uncontrolled a-cell neogenesis of Geneva Faculty of Medicine, CH-1211 Geneva 4, Switzerland and fatality caused by extreme hyperglycemia (Collombat et al. 2009). These studies on the ability of a single Using single transcription factors to reprogram cells could lineage-allocating transcription factor to sustain com- produce important insights into the epigenetic mechanisms plete cell fate conversion suggest that similar analyses that direct normal differentiation, or counter inappropriate for other transcription factors could be insightful.
    [Show full text]
  • Differential Expression of Vitamin D Binding Protein in Thyroid Cancer Health Disparities
    www.oncotarget.com Oncotarget, 2021, Vol. 12, (No. 7), pp: 596-607 Research Paper Differential expression of Vitamin D binding protein in thyroid cancer health disparities Brittany Mull1, Ryan Davis2,3, Iqbal Munir4, Mia C. Perez5, Alfred A. Simental6 and Salma Khan2,3,6,7 1Harbor UCLA Medical Center, Torrance, CA 90502, USA 2Division of Biochemistry, Loma Linda, CA 92350, USA 3Center for Health Disparities & Molecular Medicine, Loma Linda, CA 92350, USA 4Riverside University Health System, Moreno Valley, CA 92555, USA 5Department of Pathology & Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA 6Department of Otolaryngology, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA 7Department of Internal Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA Correspondence to: Salma Khan, email: [email protected] Keywords: DBP; thyroid cancer; health disparities Received: November 16, 2020 Accepted: March 05, 2021 Published: March 30, 2021 Copyright: © 2021 Mull et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Thyroid cancer incidence, recurrence, and death rates are higher among Filipino Americans than European Americans. We propose that vitamin D binding protein (DBP) with multifunctionality with ethnic variability plays a key role within different ethnicities. In this study, we determined the correlation between differential DBP expression in tumor tissues and cancer staging in Filipino Americans versus European Americans. We assayed DBP expression by immunohistochemistry and analyzed the data with confocal microscopy on 200 thyroid cancer archival tissue samples obtained from both ethnicities.
    [Show full text]
  • Functional Skeletal Muscle Constructs from Transdifferentiated Human Fibroblasts
    www.nature.com/scientificreports OPEN Functional skeletal muscle constructs from transdiferentiated human fbroblasts Bin Xu1, Allison Siehr1 & Wei Shen1,2,3* Transdiferentiation of human non-muscle cells directly into myogenic cells by forced expression of MyoD represents one route to obtain highly desirable human myogenic cells. However, functional properties of the tissue constructs derived from these transdiferentiated cells have been rarely studied. Here, we report that three-dimensional (3D) tissue constructs engineered with iMyoD-hTERT- NHDFs, normal human dermal fbroblasts transduced with genes encoding human telomerase reverse transcriptase and doxycycline-inducible MyoD, generate detectable contractile forces in response to electrical stimuli upon MyoD expression. Withdrawal of doxycycline in the middle of 3D culture results in 3.05 and 2.28 times increases in twitch and tetanic forces, respectively, suggesting that temporally- controlled MyoD expression benefts functional myogenic diferentiation of transdiferentiated myoblast-like cells. Treatment with CHIR99021, a Wnt activator, and DAPT, a Notch inhibitor, leads to further enhanced contractile forces. The ability of these abundant and potentially patient-specifc and disease-specifc cells to develop into functional skeletal muscle constructs makes them highly valuable for many applications, such as disease modeling. Even though normal skeletal muscle has self-regenerative ability, it has remained a major challenge to treat genetic muscle diseases and volumetric muscle loss 1. Using human myogenic cells to develop cell-based thera- pies to repair or restore diseased or lost muscle tissue represents an important strategy to address this challenge. Human myogenic cells are also highly desirable for creating muscle tissue models or disease models, which can be used for fundamental studies of muscle physiology and pathology and for drug screening and validation.
    [Show full text]
  • Prox1regulates the Subtype-Specific Development of Caudal Ganglionic
    The Journal of Neuroscience, September 16, 2015 • 35(37):12869–12889 • 12869 Development/Plasticity/Repair Prox1 Regulates the Subtype-Specific Development of Caudal Ganglionic Eminence-Derived GABAergic Cortical Interneurons X Goichi Miyoshi,1 Allison Young,1 Timothy Petros,1 Theofanis Karayannis,1 Melissa McKenzie Chang,1 Alfonso Lavado,2 Tomohiko Iwano,3 Miho Nakajima,4 Hiroki Taniguchi,5 Z. Josh Huang,5 XNathaniel Heintz,4 Guillermo Oliver,2 Fumio Matsuzaki,3 Robert P. Machold,1 and Gord Fishell1 1Department of Neuroscience and Physiology, NYU Neuroscience Institute, Smilow Research Center, New York University School of Medicine, New York, New York 10016, 2Department of Genetics & Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, 3Laboratory for Cell Asymmetry, RIKEN Center for Developmental Biology, Kobe 650-0047, Japan, 4Laboratory of Molecular Biology, Howard Hughes Medical Institute, GENSAT Project, The Rockefeller University, New York, New York 10065, and 5Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 Neurogliaform (RELNϩ) and bipolar (VIPϩ) GABAergic interneurons of the mammalian cerebral cortex provide critical inhibition locally within the superficial layers. While these subtypes are known to originate from the embryonic caudal ganglionic eminence (CGE), the specific genetic programs that direct their positioning, maturation, and integration into the cortical network have not been eluci- dated. Here, we report that in mice expression of the transcription factor Prox1 is selectively maintained in postmitotic CGE-derived cortical interneuron precursors and that loss of Prox1 impairs the integration of these cells into superficial layers. Moreover, Prox1 differentially regulates the postnatal maturation of each specific subtype originating from the CGE (RELN, Calb2/VIP, and VIP).
    [Show full text]
  • Rb and P53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors
    Author Manuscript Published OnlineFirst on June 26, 2020; DOI: 10.1158/0008-5472.CAN-19-2232 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Title: Rb and p53 execute distinct roles in the development of pancreatic neuroendocrine tumors 2 Running Title: Roles of Rb and p53 in pancreatic neuroendocrine tumors 3 4 1Yuki Yamauchi, 1,2Yuzo Kodama, 1Masahiro Shiokawa, 1Nobuyuki Kakiuchi, 1Saiko Marui, 5 1Takeshi Kuwada, 1Yuko Sogabe, 1Teruko Tomono, 1Atsushi Mima, 1Toshihiro Morita, 1Tomoaki 6 Matsumori, 1Tatsuki Ueda, 1Motoyuki Tsuda, 1Yoshihiro Nishikawa, 1Katsutoshi Kuriyama, 7 1Yojiro Sakuma, 1Yuji Ota, 1Takahisa Maruno, 1Norimitsu Uza, 2Atsuhiro Masuda, 3Hisato 8 Tatsuoka, 3Daisuke Yabe, 4Sachiko Minamiguchi, 5Toshihiko Masui, 3Nobuya Inagaki, 5Shinji 9 Uemoto, 1,6Tsutomu Chiba, and 1Hiroshi Seno 10 11 1Department of Gastroenterology and Hepatology, Kyoto University Graduate School of 12 Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 13 2Department of Gastroenterology, Kobe University Graduate School of Medicine, 7-5-1 14 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. 15 3Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of 16 Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 17 4Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, 54 18 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 1 Downloaded from cancerres.aacrjournals.org on September 28, 2021. © 2020 American Association for Cancer Research. Author Manuscript Published OnlineFirst on June 26, 2020; DOI: 10.1158/0008-5472.CAN-19-2232 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
    Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes Sevda Gheibi *, Tania Singh, Joao Paulo M.C.M. da Cunha, Malin Fex and Hindrik Mulder * Unit of Molecular Metabolism, Lund University Diabetes Centre, Jan Waldenströms gata 35; Box 50332, SE-202 13 Malmö, Sweden; [email protected] (T.S.); [email protected] (J.P.M.C.M.d.C.); [email protected] (M.F.) * Correspondence: [email protected] (S.G.); [email protected] (H.M.) Supplementary Table 1. Transcription factors associated with development of the pancreas. Developmental Gene Aliases Function Ref. Stage SRY-Box Transcription Factor Directs the primitive endoderm SOX17 DE, PFE, PSE [1] 17 specification. Establishes lineage-specific transcriptional programs which leads DE, PFE, PSE, Forkhead Box A2; Hepatocyte to proper differentiation of stem cells FOXA2 PMPs, EPs, [2] Nuclear Factor 3-β into pancreatic progenitors. Regulates Mature β-cells expression of PDX1 gene and aids in maturation of β-cells A pleiotropic developmental gene which regulates growth, and Sonic Hedgehog Signaling differentiation of several organs. SHH DE [3] Molecule Repression of SHH expression is vital for pancreas differentiation and development Promotes cell differentiation, proliferation, and survival. Controls C-X-C Motif Chemokine the spatiotemporal migration of the Receptor 4; Stromal Cell- CXCR4 DE angioblasts towards pre-pancreatic [4] Derived Factor 1 Receptor; endodermal region which aids the Neuropeptide Y3 Receptor induction of PDX1 expression giving rise to common pancreatic progenitors Crucial for generation of pancreatic HNF1 Homeobox B HNF1B PFE, PSE, PMPs multipotent progenitor cells and [5] Hepatocyte Nuclear Factor 1-β NGN3+ endocrine progenitors Master regulator of pancreatic organogenesis.
    [Show full text]
  • Combined Ectopic Expression of Pdx1 and Ptf1a/P48 Results in the Stable Conversion of Posterior Endoderm Into Endocrine and Exocrine Pancreatic Tissue
    Downloaded from genesdev.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press RESEARCH COMMUNICATION results reported in this communication, ectopic expres- Combined ectopic expression sion of Pdx1 in nonpancreatic chicken endoderm re- of Pdx1 and Ptf1a/p48 results sulted in the initiation of pancreatic budding, but it was not sufficient to promote differentiation of either exo- in the stable conversion crine or endocrine cells (Grapin-Botton et al. 2001). of posterior endoderm into Ptf1a/p48 is a bHLH transcription factor, which was originally identified as a part of a heterotrimeric pan- endocrine and exocrine creas transcription factor complex, referred to as PTF1 that activates transcription of exocrine specific pancre- pancreatic tissue atic genes in the mature pancreas (Cockell et al. 1989; Beres et al. 2006). Mice bearing a null mutation of Ptf1a/ Solomon Afelik, Yonglong Chen, p48 are completely devoid of exocrine pancreas, while 1 and Tomas Pieler endocrine pancreatic cells still form, but are found to be translocated to the spleen (Krapp et al. 1998). More re- Georg-August-Universität Göttingen, Zentrum Biochemie und cent studies have revealed that Ptf1a/p48 is already ex- Molekular Zellbiologie, Abteilung Entwicklungsbiochemie, pressed in pancreatic precursor cells which contribute to 37077 Göttingen, Germany all pancreatic cell types, and that, in the absence of Patterning of the embryonic endoderm into distinct sets Ptf1a/p48, pancreatic precursor cells adopt a duodenal fate (Kawaguchi et al. 2002). These findings suggest a of precursor cells involves the precisely regulated activi- role for Ptf1a/p48 that is not solely in exocrine differen- ties of key transcription regulators.
    [Show full text]
  • Genetic Drivers of Pancreatic Islet Function
    | INVESTIGATION Genetic Drivers of Pancreatic Islet Function Mark P. Keller,*,1 Daniel M. Gatti,†,1 Kathryn L. Schueler,* Mary E. Rabaglia,* Donnie S. Stapleton,* Petr Simecek,† Matthew Vincent,† Sadie Allen,‡ Aimee Teo Broman,§ Rhonda Bacher,§ Christina Kendziorski,§ Karl W. Broman,§ Brian S. Yandell,** Gary A. Churchill,†,2 and Alan D. Attie*,2 *Department of Biochemistry, §Department of Biostatistics and Medical Informatics, and **Department of Horticulture, University of Wisconsin–Madison, Wisconsin 53706-1544, †The Jackson Laboratory, Bar Harbor, Maine 06409, and ‡Maine School of Science and Mathematics, Limestone, Maine 06409, ORCID IDs: 0000-0002-7405-5552 (M.P.K.); 0000-0002-4914-6671 (K.W.B.); 0000-0001-9190-9284 (G.A.C.); 0000-0002-0568-2261 (A.D.A.) ABSTRACT The majority of gene loci that have been associated with type 2 diabetes play a role in pancreatic islet function. To evaluate the role of islet gene expression in the etiology of diabetes, we sensitized a genetically diverse mouse population with a Western diet high in fat (45% kcal) and sucrose (34%) and carried out genome-wide association mapping of diabetes-related phenotypes. We quantified mRNA abundance in the islets and identified 18,820 expression QTL. We applied mediation analysis to identify candidate causal driver genes at loci that affect the abundance of numerous transcripts. These include two genes previously associated with monogenic diabetes (PDX1 and HNF4A), as well as three genes with nominal association with diabetes-related traits in humans (FAM83E, IL6ST, and SAT2). We grouped transcripts into gene modules and mapped regulatory loci for modules enriched with transcripts specific for a-cells, and another specific for d-cells.
    [Show full text]